Komori
Qol Holdings (3034) · FactNumber of consolidated subsidiaries updated

Two-segment structure comprising the dispensing pharmacy business and outsourced BPO services

First written in FY2016. 6 of 17 entries say "Restated". Latest entry: FY2026.

17entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseReframedFY2020-Q3 – FY2021OtherFY2022 – FY2024ReframedFY2025-H12016: 120162017: 320172018: 320182019: 320192020: 120202021: 120212022: 120222023: 020232024: 320242025: 020252026: 12026
Same theme, other companies
Health insurance pharmacy and contracted BPO business segment structureA theme 1 companies write about · 0 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026Number of consolidated subsidiaries updatedAnnual report

    「The Group (the Company and its affiliated companies) consists of Qol Holdings Co.,Ltd. (the Company) and 28 consolidated subsidiaries, and operates pharmacy, BPO and pharmaceutical businesses.」

    The Group continues with a three-business structure, and reports 28 consolidated subsidiaries.
  2. FY2025-H1ReframedAnnual report

    「From the current interim consolidated accounting period, the business segments disclosed as reportable segments have been changed from the two categories of "Community Pharmacy Business" and "Healthcare-Related Business" to the three categories of "Pharmacy Business," "BPO Business" and "Pharmaceutical Business."」

    Following the conversion of 第一三共エスファ株式会社 into a consolidated subsidiary, the reporting classification of the business structure was changed from the previous two categories, pharmacy and healthcare-related, to three categories: pharmacy, BPO and pharmaceuticals.
  3. FY2024Update to the composition of consolidated subsidiaries and affiliatesAnnual report

    「The Group (the Company and its affiliated companies) consists of Qol Holdings Co.,Ltd. (the Company), 27 consolidated subsidiaries and 1 affiliate, and operates community pharmacy and healthcare-related businesses.」

    At fiscal year-end, the Group structure comprised the community pharmacy and healthcare-related businesses, with 27 consolidated subsidiaries and 1 affiliate.
  4. FY2024-Q3Addition of an equity-method affiliateAnnual report

    「In the healthcare-related business, during the current third quarter, the Group acquired a 30% stake in 第一三共エスファ株式会社, making it an equity-method affiliate.」

    The Group added 第一三共エスファ株式会社 to its structure as an equity-method affiliate after acquiring a 30% stake.
  5. FY2022Decrease in the number of consolidated subsidiariesAnnual report

    「The Group consists of Qol Holdings Co.,Ltd. (the Company), 23 consolidated subsidiaries and 1 other affiliated company, and operates community pharmacy and healthcare-related businesses.」

    The Group maintains a two-segment structure comprising the community pharmacy and healthcare-related businesses, while the number of consolidated subsidiaries is 23.
  6. FY2021ReframedAnnual report

    「The Group consists of Qol Holdings Co.,Ltd. (the Company), 33 consolidated subsidiaries, 1 unconsolidated subsidiary and 1 other affiliated company, and operates community pharmacy and healthcare-related businesses.」

    The former two-pillar structure of community pharmacy and BPO has been renamed for reporting purposes as the healthcare-related business, which includes the pharmaceutical manufacturing and marketing business.
  7. FY2020-Q3ReframedAnnual report

    「The Group has traditionally had community pharmacy and BPO as its two main sources of earnings, but, as an important business strategy for achieving its medium-term targets, it acquired all shares of 藤永製薬株式会社 on 8 August 2019 and entered the pharmaceutical manufacturing and marketing business as its third business.」

    In addition to its traditional two main sources of earnings, the Group entered the pharmaceutical manufacturing and marketing business. Although the reporting segment classification remains unchanged, the business structure has expanded to include a third business.
  8. FY2020-Q1RestatedAnnual report

    「Against this backdrop, the Group's two main sources of earnings are its community pharmacy and BPO businesses.」

    The Group continues with its current business structure, based on community pharmacy and BPO as its two main sources of earnings.
  9. FY2019AdvancedAnnual report

    「The Group consists of Qol Holdings Co.,Ltd. (the Company), 34 consolidated subsidiaries, 1 unconsolidated subsidiary and 1 other affiliated company, and operates community pharmacy and BPO businesses.」

    Under the holding company structure, the Group has a two-segment structure comprising the community pharmacy and BPO businesses, with 34 consolidated subsidiaries and other entities.
  10. FY2019-Q3RestatedAnnual report

    「The Group's two main sources of earnings are its community pharmacy and BPO businesses.」

    The Group continues to have a business structure based on community pharmacy and BPO as its two main sources of earnings.
  11. FY2019-Q2ReframedAnnual report

    「The Group's two main sources of earnings are its community pharmacy and BPO businesses.」

    The structure based on two main sources of earnings continues, but the business name has changed from "BPO Services Business" to "BPO Business."
  12. FY2019-Q1RestatedAnnual report

    「The Group's two main sources of earnings are its community pharmacy and BPO services businesses.」

    The Group continues to have a structure based on community pharmacy and BPO services as its two main sources of earnings.
  13. FY2018-Q3RestatedAnnual report

    「The Group's two main sources of earnings are its community pharmacy and BPO services businesses」

    The Group continues to have a structure based on community pharmacy and BPO services as its two main sources of earnings.
  14. FY2018-Q2RestatedAnnual report

    「The Group's two main sources of earnings are its community pharmacy and BPO services businesses」

    The Group continues to have a structure based on community pharmacy and BPO services as its two main sources of earnings.
  15. FY2018-Q1RestatedAnnual report

    「The Group's two main sources of earnings are its community pharmacy and BPO services businesses.」

    The Group continues to have a structure based on community pharmacy and BPO services as its two main sources of earnings.
  16. FY2017AdvancedAnnual report

    「The Group consists of クオール株式会社 (the Company), 20 consolidated subsidiaries, 1 unconsolidated subsidiary and 1 other affiliated company, and operates community pharmacy and BPO services businesses.」

    Following mergers of subsidiaries and other changes, the Group has a two-segment structure consisting of 20 consolidated subsidiaries and other entities.
  17. FY2016First statedAnnual report

    「The Group consists of クオール株式会社 (the Company), 25 consolidated subsidiaries and 1 other affiliated company, and operates community pharmacy and BPO services businesses.」

    The Group, including 25 consolidated subsidiaries, consists of 2 business segments.
Moved together

"Selective Focus and Concentration in the BPO Outsourcing Business" moved the same way as this thread, in the same document, in 3 of its 17 moves.

332222★123456
  1. ★This thread
  2. 1Selective Focus and Concentration in the BPO Outsourcing Business3×
  3. 2Revenue and Profit Growth3×
  4. 3Expansion of Store Count, Including Acquisitions2×
  5. 4Business Expansion through M&A2×
  6. 5Track Record of Expanding the Health Insurance Pharmacy Network2×
  7. 6Insurance Pharmacy Store Base2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Qol Holdings's next results are scheduled for 2026-11-05. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Two-segment structure comprising the dispensing pharmacy business and outsourced BPO services | Qol Holdings Co.,Ltd. (3034) | Komori